Results come at the decision point for practices: Will it be 1-sided or 2-sided risk?
Oncology practices already taking part in CMS’ alternative payment model, the Oncology Care Model (OCM), are willing to take on 2-sided risk, according to results of a survey by the Community Oncology Alliance (COA) released Friday.
Survey results show that oncology practices believe they can deliver high quality, cost-effective care to patients with cancer while the reimbursement system transitions from a fee-for-service model to one that rewards outcomes, also known as a value-based system.
COA surveyed OCM practices after the December 3, 2019, deadline set by the Center for Medicare and Medicaid Innovation (or CMS Innovation Center), at which point practices had to make a firm commitment about their path forward:
Results from the 68 practices that responded to the 15-question survey showed:
COA’s Director of Strategic Initiatives, Bo Gamble, said in a statement that results show oncology practices are gaining confidence with alternate payment models in the years since the OCM launched. “No longer are incentives purely about utilization. Now there are numerous attempts to design a model with emphasis on quality, value, and meaningful quantifiable outcomes,” he said. “The OCM, and the 20-plus other models, are consistent with that message.”
The OCM, launched in 2016 by CMS’ Innovation Center, is a 5-year pilot model designed to help both oncology practices and Medicare learn how to reward practices for things like doing a better job with care coordination, palliative care, having the flexibility to schedule same-day appointments, and developing survivorship plans with patients. Under the model, practices must meet financial and performance targets for episodes of care surrounding patient treatment. Besides Medicare, CMS partners with commercial payers in the model.
While most observers say the OCM has vastly improved the quality of care, studies have shown that the model does not always adequately cover the cost of innovative therapies, as some of today’s blockbuster treatments reached the market after the pilot was under way. A successor model, called Oncology Care First, has been proposed to address some of these issues.
According to data collected by COA, practices taking on 2-sided risk represent 679 physicians. The average practice size that accepting 2-sided risk is 29.5 physicians (the largest has 160, the smallest has 2).
Of the responding practices, 3 that said they had achieved a performance-based payment during the previous 4 performance periods reported they were entering the 2-sided risk arrangement. According to COA, 22 practices, or 32.4%, were continuing in the OCM with 2-sided even though they had never received a performance-based payment.
“These teams must feel good about their progress or they were comfortable with the safe zone option,” Gamble said. He said 7 practices were in the safe zone for all 4 performance periods; 5 were in the safe zone for 3 performance periods; 9 were in the safe zone for 2 performance periods; and 2 practices were in the safe zone for 1 performance period.
The “safe zone,” introduced by CMS with the performance period 3 reconciliation reports, happens costs fall between the OCM’s targeted and benchmark costs. No performance-based payment is awarded, but no money would be owed, either.
Base-Edited T Cells Could Minimize Immunotherapy Complications in Leukemia, Study Suggests
November 18th 2023The use of base editing to generate universal, off-the-shelf CAR T cells is a promising approach for relapsed leukemia, with potential implications for the future of gene therapy.
Read More
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
EOM Shows Awareness of Issues, but Provides No Resources, Says COA’s Nicolas Ferreyros
November 4th 2023The Enhancing Oncology Model is trying to address a number of the systemic challenges oncology faces without giving practices the tools and resources they need, said Nicolas Ferreyros, managing director of policy, advocacy, and communications, Community Oncology Alliance.
Read More
High Disease Burden at Acute Leukemia Diagnosis More Common in Black Children, Study Finds
November 3rd 2023A study evaluating disparities among children with acute leukemia found that Black children are more likely to present with higher disease burden at diagnosis compared with non-Hispanic White children.
Read More